Skip to main content

Table 3 The patients’ clinical and radiographic manifestations according to pulmonary CMV infection status

From: Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study

 

CMV-DNA positive in BALF

CMV-DNA negative in BALF

p

Symptoms, n (%)

fever

31 (81.6%)

28 (87.5%)

0.50

dyspnea

29 (76.3%)

17 (53.1%)

0.04

CT findings

ground-glass opacities

38/38 (100.0%)

32/32 (100.0%)

1.00

consolidations

18/38 (47.4%)

15/32 (46.9%)

0.97

centrilobular nodules

14/38 (36.8%)

3/32 (9.4%)

0.008

upper lobe predominance

7/38 (18.4%)

8/32 (25.0%)

0.50

  1. CMV cytomegalovirus, BALF bronchoalveolar lavage fluid, CT computed tomography
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us